Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature
about
Striatal neuroprotection with methylene blue.Dose escalation study for defining the maximum tolerated dose of continuous oral trofosfamide in pretreated patients with metastatic lung cancer.A novel trial of topotecan, ifosfamide, and carboplatin (TIC) in children with recurrent solid tumors.Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell TransplantationNeurologic Emergencies in the Patients With Cancer.Oxazaphosphorines: new therapeutic strategies for an old class of drugs.Methylene blue as an antimalarial agent.Efficacy of intravenous methylene blue, intravenous artesunate, and their combination in preclinical models of malaria.Cellular and molecular actions of Methylene Blue in the nervous systemResistance of human butyrylcholinesterase to methylene blue-catalyzed photoinactivation; mass spectrometry analysis of oxidation products.Methylene blue: revisited.Methylene Blue--a therapeutic dye for all seasons?Simultaneous quantification of methylene blue and its major metabolite, azure B, in plasma by LC-MS/MS and its application for a pharmacokinetic study.Acute liver toxicity with ifosfamide in the treatment of sarcoma: a case reportHIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era.Fatal Ifosfamide-induced metabolic encephalopathy in patients with recurrent epithelial ovarian cancer: report of two cases.Methylthioninium chloride: pharmacology and clinical applications with special emphasis on nitric oxide mediated vasodilatory shock during cardiopulmonary bypass.Liposomal muramyl tripeptide phosphatidyl ethanolamine: ifosfamide-containing chemotherapy in osteosarcoma.Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease modelsNRF2 and the Phase II Response in Acute Stress Resistance Induced by Dietary Restriction.Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents.Novel Vitamin K analogs suppress seizures in zebrafish and mouse models of epilepsy.Pharmacotherapy of sarcoma.Behavioral, Physiological and Biochemical Hormetic Responses to the Autoxidizable Dye Methylene Blue.Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neurotoxicity.Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue.Central nervous system toxicities of chemotherapeutic agents.Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals.Successful treatment of ifosfamide neurotoxicity with dexmedetomidine.Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report.Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant.Nonconvulsive status epilepticus due to ifosfamide.Methylene blue rescues heart defects in a Drosophila model of Friedreich's ataxia.Methylene Blue for the Treatment of Intractable Pain Associated with Oral Mucositis.Suspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy.Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue.Methylene Blue for Acute Septic Cardiomyopathy in a Burned Patient.Analysis of methylene blue and its metabolites in blood by capillary electrophoresis/electrospray ionization mass spectrometry.Anisocoria and an Array of Neurologic Symptoms in an Adult With Ewing Sarcoma.
P2860
Q30479074-CC8B8F85-A4A8-4A46-8C4E-143F27DC7CEFQ33364099-8384DAE8-9FBB-47A7-81AE-6E33A14AD654Q33418620-BA49E517-C35E-4B4B-939C-C9A9CB0048AEQ33679931-BCCB12BA-AF7B-4C8D-B7A4-24BE0BF029C4Q33806844-A681F040-9DA0-42B3-A299-4CD69EB17B68Q34113899-6DBE7E27-4CCF-43C2-B29E-7FE36B38B0E8Q34298547-BF553480-32CE-49D8-85F7-4A61A4D5B1C5Q34409963-A4ECEC3D-3DFE-420D-A5DD-4A2269F51F37Q34422385-41EA39C1-1EBE-4E21-8AC3-01642E36CADAQ34471002-7B2E8B1E-B0F8-494A-AA5F-19AFFF0602FAQ34921079-FB7768DB-A1AF-43A3-8C77-B70740800AD9Q35014719-09B6C651-5049-4E6F-8BBF-A1D70C12B042Q35016575-B02B876B-D44E-49FD-BCBC-689E681F5FDFQ35053067-14BA1A57-E4A2-42BB-A5F6-C94035B9C660Q35606384-7130D6B0-7928-4308-93C7-44FBF6A93DFCQ35661073-B9E93427-DE2B-46E6-975B-556E55B3A8DBQ36140718-E56E929C-3580-4492-88B8-4F525A882443Q36512499-BCCAFF53-7560-4995-ABB9-85A949DED021Q36538885-4ED16425-9AA6-49B5-8144-7192F4774097Q36678635-C672AD5B-B1D6-44E8-A524-54C591221CF6Q36913723-ACF94EAE-88C1-4540-B04C-1F7DDDE66B39Q37038352-8E36BDC5-EC3C-42B8-AE4A-5B89CEE1E5C5Q37521578-25BBF0B9-F151-4968-BE32-50D20F380C11Q37532566-520909CD-F4C6-4228-BCAA-7120FA27A3E4Q37750487-D29B5798-0471-4B5D-BD06-522A665AA655Q37791283-FBBAAC3E-A201-40BC-82B5-28AE646F9D61Q37954003-B2513C36-27F5-4DC4-ADCF-356BADB4E32BQ38205470-D0991953-D6F9-4B9E-A7E5-6C7246FD6B15Q41677104-79661D27-8B3A-4444-A681-874AEBF6ED02Q43179429-1A8102AF-0617-43F7-90B9-7C45220D3ECCQ43880501-823E44C4-3C96-4191-A964-90757A9B8B47Q46417406-3FB7ADB8-34A1-4955-8987-76B2F57AA5BBQ46921571-AA3E3A53-C708-4973-B070-E8035D3BBB93Q47072694-D028FA16-095A-4E1B-9154-4D83CD04AD6AQ47327037-00202C79-8455-4CBE-9EE6-1198BAAFE512Q48196500-666A7BB7-7D35-42E3-B261-A8E886E87482Q49627984-3894C95F-788B-470C-AFC0-48241E0E6146Q50216192-ED2FEE5D-FD06-4F4A-814B-1C83FE33A6A2Q50282762-512AA2A2-ED65-411C-9F50-20FC92B78554Q55107189-E7F24F2A-E4C1-441F-B2A8-C17F5ABBF1E6
P2860
Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Methylene blue in the treatmen ...... and a review of the literature
@ast
Methylene blue in the treatmen ...... and a review of the literature
@en
Methylene blue in the treatmen ...... and a review of the literature
@nl
type
label
Methylene blue in the treatmen ...... and a review of the literature
@ast
Methylene blue in the treatmen ...... and a review of the literature
@en
Methylene blue in the treatmen ...... and a review of the literature
@nl
prefLabel
Methylene blue in the treatmen ...... and a review of the literature
@ast
Methylene blue in the treatmen ...... and a review of the literature
@en
Methylene blue in the treatmen ...... and a review of the literature
@nl
P2093
P2860
P921
P356
P1476
Methylene blue in the treatmen ...... and a review of the literature
@en
P2093
D Schrijvers
J B Vermorken
J Pelgrims
J Van den Brande
P2860
P2888
P356
10.1054/BJOC.1999.0917
P407
P577
2000-01-01T00:00:00Z
P5875
P6179
1031641848